Pediatric Lyme disease: systematic assessment of post-treatment symptoms and quality of life

Monaghan, Maureen; Norman, Stephanie A.; Gierdalski, Marcin; Marques, Adriana; Bost, James E.; DeBiasi, Roberta L.

doi:10.1038/s41390-023-02577-3

Cited by 4 publications

(1 citation statement)

References 39 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Regardless of their underlying diagnoses, many patients diagnosed with 'chronic Lyme disease' have significant disability from their symptoms [7]. Children with Lyme disease are less likely to develop PTLDS [13 provide benefit and exposes these patients to significant risk [7].…”

Section: Andandmentioning

confidence: 99%

Tick-borne infections in children in North America

Taylor-Salmon,

Shapiro

2024

Current Opinion in Pediatrics

View full text Add to dashboard Cite

Purpose of review Because both incidence and awareness of tick-borne infections is increasing, review of major infections and recent advances related to their diagnosis and management is important. Recent findings A new algorithm, termed modified two-tier testing, for testing for antibodies to Borrelia burgdorferi, the cause of Lyme disease, has been approved and may replace traditional two-tier testing. In addition, doxycycline is now acceptable to use for treatment of and/or prophylaxis for Lyme disease for up to 21 days in children of any age. Borrelia miyamotoi, a bacterium in the relapsing fever type of Borrelia, is the first of this type of Borrelia that is transmitted by hard-bodied ticks such as Ixodes scapularis. Summary Awareness of these infections and advances in their diagnosis and treatment is important to assure the best outcomes for affected patients. Table 1 contains a summary of infections discussed.

show abstract

Section: Andandmentioning

confidence: 99%